ARTICLE | Distillery Therapeutics
Infectious disease
February 28, 2017 11:51 PM UTC
Studies in cells suggest a bacterial toxin-based inhibitor of US28 could help treat latent CMV infection. In a human monocyte cell line expressing US28, a fusion protein consisting of the US28-binding...
BCIQ Company Profiles